CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 247 enrolled
Drug / intervention
Dyspnea Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03089125
NCT03089125N/ACompleted

Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Massachusetts General Hospital·interventional·Posted Mar 24, 2017·Updated Feb 27, 2025

In Brief

A clinical study evaluating Dyspnea Intervention and Usual Care for Lung Cancer. Completed, enrolled 247 participants across 2 sites.

Detailed Summary

This research study is evaluating a behavioral intervention designed to help people with advanced lung cancer manage dyspnea (i.e., breathlessness or shortness-of-breath).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 24, 2017
Enrollment StartMay 15, 2017
Primary CompletionOct 26, 2022
Study CompletionApr 6, 2023
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 9.3 years ago

Interventions

Dyspnea Interventionbehavioral

Dyspnea intervention will be administered over two sessions Patients will receive: * Psychoeducation * Relaxation training for reducing physiological stress * Behavioral techniques for managing acute breathlessness

Usual Careother

Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians